ADHERENCE TO STATIN THERAPY UNDER DRUG COST SHARING IN PATIENTS WITH AND WITHOUT ACUTE MYOCARDIAL INFARCTION: A POPULATION-BASED NATURAL EXPERIMENT, by Schneeweiss et al.
Financial barriers to medication use are associated with worse outcomes for patients with acute myocardial infarction. These barriers can affect medication use even for patients with health insurance, raising questions about how coverage for medications affects patient behavior. Investigators were able to take advantage of a natural experiment in British Columbia, where an evolution of coverage occurred over a 4-year period. In 2001, full drug coverage existed, whereas in 2002, a $10 or $25 copay was instituted, and in 2003-2004, 25% coinsurance was implemented. The study examines the effect of these coverage policies on adherence to new statin therapy for patients after acute myocardial infarction and initiation of statin therapy. This study by Schneeweiss et al has important implications for national discussions about the consequences of imposing a patient payment component on medication coverage. See p 2128.
PREDICTORS OF OUTCOME IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, by Bonderman et al.
Chronic thromboembolic pulmonary hypertension is an infrequently encountered clinical syndrome. However, unlike many other causes of pulmonary hypertension, it is potentially amenable to a direct therapy, surgical pulmonary endarteretomy. Most series of chronic thromboembolic pulmonary hypertension patients are relatively small, and thus, characteristics of patients who may or may not have higher-risk prognosis or be better surgical candidates are not well defined. In this issue of Circulation, Bonderman and colleagues report on a large single-center series including all chronic thromboembolic pulmonary hypertension patients referred for consideration of pulmonary endarteretomy in Austria over a 15-year span. Over a median of Ϸ2 years follow-up in this observational series, the presence of comorbidities such as splenectomy, ventriculoatrial shunt, permanent central intravenous lines, inflammatory bowel disease, and osteomyelitis was associated with unfavorable outcomes. Pulmonary endarteretomy was associated with reduction in risk of death, but the presence of those comorbidities increased the chance of postoperative mortality or persistent pulmonary hypertension. These data should allow more informed decision making for this challenging syndrome. See p 2153.
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The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management. See p e422.
